arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Progyny, Inc.

PGNY Health Care Misc Health and Biotechnology Services
$25.94
Today
as of Sep 4, 16:53 ET
Last 30 days -15.67% Jul 28 → Sep 04
$24.83 $26.63 $28.43 $30.23 $32.03 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$26.51
High
$26.66
Low
$25.82
Volume
$1M
Avg Vol
$1M
Mkt Cap
$2.0B
P/E (TTM)
41.27
Beta
—
52w High
$33.06
52w Low
$16.10
Div Yield
—
Shares Out
$77M

Recent Press Releases & News last 60 days · 25 items

Sep 3 · 15:16 PR GlobeNewswire
Progyny, Inc. to Present at the Wells Fargo Healthcare Conference
Aug 20 · 10:53 MT Newswires
Wells Fargo Initiates Progyny at Overweight With $37 Price Target
Aug 16 · 11:01 MarketBeat
Progyny Sees Utilization Rebound as Early Renewals De-Risk Outlook
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$16
$33
58% of range
Avg surprise (last 3)
+9.0%
Avg reaction (last 2)
+1.1%
50% positive
Latest IV / EM
68%
EM ±10.6% · $25 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$0.17$0.21$0.26$0.30$0.34 Actual $0.17Est $0.18Actual $0.19Est $0.17Actual $0.29Est $0.24Actual $0.34 Mar/2025Jun/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$0$92M$184M$276M$368M Mar 25Jun 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $0.34 — — — — financials
Thu May 7, 2026Mar/2026 $0.29 $0.24 +20.8% +70.6% +2.5% earnings
Thu Aug 7, 2025Jun/2025 $0.19 $0.17 +11.8% — — earnings
Thu May 8, 2025Mar/2025 $0.17 $0.18 -5.6% — -0.2% earnings

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$351M$329M——$333M$324M——
Cost of revenue$261M$245M——$254M$248M——
Gross profit$89M$83M——$79M$76M——
Operating income$40M$35M——$24M$24M——
Net income$28M$24M——$17M$15M——
EPS (diluted)$0.34$0.29——$0.19$0.17——

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$153M$132M$112M$134M$133M$109M$162M$91M
Inventory————————
Total current assets$513M$502M$552M$622M$594M$568M$473M$546M
Total assets$716M$698M$742M$795M$761M$730M$607M$660M
Long-term debt————————
Total liabilities$263M$259M$226M$235M$246M$263M$185M$225M
Total equity$453M$439M$516M$560M$515M$467M$422M$435M

Implied volatility — last 90 days

33%106%178%251%324% Jun 07 — IV 51% · EM ±7.1%Jun 08 — IV 48% · EM ±6.4%Jun 09 — IV 50% · EM ±6.3%Jun 10 — IV 56% · EM ±6.6%Jun 11 — IV 85% · EM ±9.4%Jun 12 — IV 128% · EM ±13.1%Jun 15 — IV 218% · EM ±15.8%Jun 16 — IV 232% · EM ±13.7%Jun 17 — IV 268% · EM ±11.2%Jun 19 — IV 43% · EM ±9.6%Jun 22 — IV 46% · EM ±9.6%Jun 23 — IV 46% · EM ±9.5%Jun 24 — IV 55% · EM ±11.0%Jun 25 — IV 53% · EM ±10.3%Jun 26 — IV 55% · EM ±10.5%Jun 29 — IV 38% · EM ±6.7%Jun 30 — IV 42% · EM ±7.2%Jul 01 — IV 45% · EM ±7.6%Jul 02 — IV 33% · EM ±5.4%Jul 03 — IV 34% · EM ±5.4%Jul 06 — IV 60% · EM ±8.4%Jul 07 — IV 43% · EM ±5.6%Jul 08 — IV 45% · EM ±5.7%Jul 09 — IV 56% · EM ±6.6%Jul 10 — IV 61% · EM ±6.8%Jul 13 — IV 144% · EM ±12.0%Jul 14 — IV 190% · EM ±13.8%Jul 15 — IV 241% · EM ±14.2%Jul 16 — IV 324% · EM ±13.5%Jul 20 — IV 62% · EM ±14.7%Jul 21 — IV 69% · EM ±16.1%Jul 22 — IV 67% · EM ±15.4%Jul 23 — IV 66% · EM ±14.9%Jul 24 — IV 73% · EM ±16.2%Jul 27 — IV 78% · EM ±16.3%Jul 28 — IV 74% · EM ±15.2%Jul 29 — IV 72% · EM ±14.5%Jul 30 — IV 75% · EM ±14.7%Jul 31 — IV 70% · EM ±13.5%Aug 03 — IV 91% · EM ±16.1%Aug 04 — IV 86% · EM ±14.9%Aug 05 — IV 89% · EM ±14.8%Aug 06 — IV 154% · EM ±24.8%Aug 07 — IV 47% · EM ±7.4%Aug 10 — IV 104% · EM ±14.4%Aug 11 — IV 120% · EM ±15.8%Aug 12 — IV 53% · EM ±6.7%Aug 13 — IV 47% · EM ±5.5%Aug 14 — IV 51% · EM ±5.6%Aug 17 — IV 56% · EM ±4.6%Aug 18 — IV 71% · EM ±5.2%Aug 19 — IV 63% · EM ±3.7%Aug 20 — IV 198% · EM ±8.3%Aug 24 — IV 35% · EM ±7.4%Aug 25 — IV 37% · EM ±7.5%Aug 26 — IV 54% · EM ±10.8%Aug 27 — IV 82% · EM ±16.2%Aug 28 — IV 85% · EM ±16.3%Aug 31 — IV 52% · EM ±9.2%Sep 01 — IV 57% · EM ±9.7%Sep 02 — IV 46% · EM ±7.7%Sep 03 — IV 96% · EM ±15.6%Sep 04 — IV 68% · EM ±10.6%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in